Conversely, accumulating evidence showed that SCFAs act through GPR41 and GPR43 in L cells to promote peptide YY (PYY) and GLP-1 and alter satiety and energy intake, which further alleviates obesity or NAFLD indirectly (33). This evidence concerns the gene FFAR2 and obesity disorder.